Barry Ira Rosenblum, D.P.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Foot | 16 | 2023 | 382 | 2.470 |
Why?
|
| Foot Diseases | 4 | 2019 | 148 | 0.870 |
Why?
|
| Wound Healing | 8 | 2023 | 2800 | 0.850 |
Why?
|
| Foot | 9 | 2015 | 576 | 0.710 |
Why?
|
| Foot Deformities, Acquired | 1 | 2020 | 27 | 0.690 |
Why?
|
| Flatfoot | 1 | 2020 | 60 | 0.650 |
Why?
|
| Arthrodesis | 1 | 2020 | 187 | 0.610 |
Why?
|
| Foot Ulcer | 5 | 2023 | 62 | 0.520 |
Why?
|
| Amnion | 1 | 2016 | 204 | 0.480 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2015 | 76 | 0.480 |
Why?
|
| Tissue Engineering | 2 | 2015 | 1861 | 0.470 |
Why?
|
| Shoes | 2 | 2014 | 91 | 0.440 |
Why?
|
| Arthropathy, Neurogenic | 3 | 2005 | 29 | 0.430 |
Why?
|
| Bone Substitutes | 1 | 2015 | 230 | 0.420 |
Why?
|
| Orthotic Devices | 1 | 2014 | 131 | 0.420 |
Why?
|
| Standard of Care | 1 | 2016 | 569 | 0.380 |
Why?
|
| Diabetic Neuropathies | 6 | 2009 | 409 | 0.340 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1655 | 0.290 |
Why?
|
| Metatarsus | 4 | 1995 | 18 | 0.250 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2212 | 0.220 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2005 | 243 | 0.210 |
Why?
|
| Ankle | 2 | 2015 | 353 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2020 | 12250 | 0.160 |
Why?
|
| Toes | 1 | 2019 | 209 | 0.150 |
Why?
|
| Biological Dressings | 1 | 2016 | 30 | 0.130 |
Why?
|
| Skin, Artificial | 1 | 2016 | 89 | 0.120 |
Why?
|
| Toe Joint | 1 | 1994 | 19 | 0.120 |
Why?
|
| Technology Transfer | 1 | 2015 | 41 | 0.120 |
Why?
|
| Sampling Studies | 1 | 2016 | 614 | 0.120 |
Why?
|
| Hallux | 1 | 1994 | 43 | 0.110 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2016 | 372 | 0.110 |
Why?
|
| Arthroplasty | 1 | 1994 | 308 | 0.100 |
Why?
|
| Metatarsal Bones | 1 | 1993 | 111 | 0.100 |
Why?
|
| Collagen | 2 | 2016 | 2636 | 0.090 |
Why?
|
| Foot Deformities | 1 | 2011 | 35 | 0.090 |
Why?
|
| Weight-Bearing | 1 | 2014 | 532 | 0.090 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 5886 | 0.090 |
Why?
|
| Diabetes Complications | 2 | 1993 | 1319 | 0.080 |
Why?
|
| Metatarsophalangeal Joint | 1 | 2009 | 41 | 0.080 |
Why?
|
| Orthopedic Procedures | 2 | 2011 | 1279 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 1994 | 1271 | 0.070 |
Why?
|
| Diabetic Nephropathies | 1 | 1994 | 974 | 0.070 |
Why?
|
| Humans | 27 | 2023 | 767040 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 1995 | 3449 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15925 | 0.060 |
Why?
|
| Calcaneus | 1 | 2007 | 144 | 0.060 |
Why?
|
| Ischemia | 1 | 1994 | 1905 | 0.060 |
Why?
|
| External Fixators | 1 | 2005 | 99 | 0.060 |
Why?
|
| Arthroplasty, Replacement | 1 | 2009 | 311 | 0.060 |
Why?
|
| Ulcer | 1 | 2023 | 203 | 0.050 |
Why?
|
| Aged | 10 | 2020 | 171319 | 0.050 |
Why?
|
| Middle Aged | 13 | 2019 | 223233 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2016 | 65295 | 0.040 |
Why?
|
| Female | 12 | 2020 | 396660 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2011 | 3964 | 0.040 |
Why?
|
| Alginates | 1 | 1998 | 248 | 0.030 |
Why?
|
| Bandages | 1 | 1998 | 271 | 0.030 |
Why?
|
| Male | 11 | 2020 | 364203 | 0.030 |
Why?
|
| Reoperation | 2 | 1997 | 4325 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 24299 | 0.030 |
Why?
|
| Quality of Life | 1 | 2016 | 13485 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2016 | 81659 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4968 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 1995 | 377 | 0.030 |
Why?
|
| Joints | 1 | 1995 | 324 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 36582 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 1995 | 166 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1995 | 498 | 0.030 |
Why?
|
| Methods | 1 | 1993 | 1065 | 0.030 |
Why?
|
| Adult | 9 | 2016 | 223317 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 54886 | 0.020 |
Why?
|
| Chronic Disease | 2 | 1997 | 9362 | 0.020 |
Why?
|
| United States | 2 | 2016 | 72971 | 0.020 |
Why?
|
| Arteries | 1 | 1994 | 1123 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1997 | 1680 | 0.020 |
Why?
|
| Phosphocreatine | 1 | 2009 | 259 | 0.020 |
Why?
|
| Treatment Failure | 1 | 1994 | 2658 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 2009 | 251 | 0.020 |
Why?
|
| Walking | 1 | 1994 | 1201 | 0.020 |
Why?
|
| Reference Values | 2 | 2009 | 4918 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 198 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 2007 | 15824 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1994 | 1390 | 0.020 |
Why?
|
| Phosphates | 1 | 2009 | 765 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1993 | 2765 | 0.010 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 488 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1994 | 6310 | 0.010 |
Why?
|
| Foot Bones | 1 | 2003 | 23 | 0.010 |
Why?
|
| Aged, 80 and over | 5 | 1998 | 59548 | 0.010 |
Why?
|
| Foot Joints | 1 | 2003 | 34 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1994 | 39317 | 0.010 |
Why?
|
| Recurrence | 1 | 1994 | 8504 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2007 | 1628 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 1396 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2009 | 2906 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 1547 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4424 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3488 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1998 | 580 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14672 | 0.010 |
Why?
|
| Metacarpus | 1 | 1995 | 37 | 0.010 |
Why?
|
| Cilastatin | 1 | 1994 | 12 | 0.010 |
Why?
|
| Sulbactam | 1 | 1994 | 32 | 0.010 |
Why?
|
| Imipenem | 1 | 1994 | 38 | 0.010 |
Why?
|
| Ampicillin | 1 | 1994 | 137 | 0.010 |
Why?
|
| Risk Factors | 4 | 2007 | 74886 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20169 | 0.010 |
Why?
|
| Time Factors | 1 | 1994 | 40154 | 0.010 |
Why?
|
| Pressure | 1 | 1995 | 1172 | 0.010 |
Why?
|
| Debridement | 1 | 1994 | 494 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1994 | 408 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 10869 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 1995 | 1829 | 0.000 |
Why?
|
| Diarrhea | 1 | 1994 | 1319 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1994 | 8535 | 0.000 |
Why?
|
| Pain | 1 | 1995 | 5101 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1994 | 12451 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1995 | 22254 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 89046 | 0.000 |
Why?
|